Novartis Hit With $250K Verdict In Zometa Jaw Injury Suit

Law360, New York (March 4, 2013, 8:00 PM EST) -- A Florida jury slapped Novartis Pharmaceuticals Corp. with a $250,000 verdict on Wednesday in multidistrict litigation over injuries allegedly caused by the bone drug Zometa, though it declined to impose punitive damages on the drugmaker.

The plaintiff, Florida resident J. Hunter Chiles, claimed that Novartis failed to warn that Zometa, a bisphosphonate he took to treat his multiple myeloma, could cause the bone disease osteonecrosis of the jaw. The suit is part of the multidistrict litigation targeting Zometa and an older Novartis bone drug, Aredia....
To view the full article, register now.